A needle in the neck to shock the heart back to life?
NCT ID NCT04168970
First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time
Summary
This trial tests whether injecting a local anesthetic into a nerve cluster in the neck—called a stellate ganglion block—can help stop dangerous heart rhythms in people who suffer a cardiac arrest outside a hospital. The study includes adults whose heart stops with a shockable rhythm that does not respond to repeated defibrillator shocks. Researchers will measure whether the procedure terminates the abnormal rhythm and restores a normal heartbeat, comparing outcomes to historical cases.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Percutaneous stellate ganglion block: an injection of local anesthetic (lidocaine) into the neck to calm overactive heart nerves during cardiac arrest.
- What this could lead to
- If effective, this quick nerve-block procedure could become a rescue tool for emergency teams, potentially stopping fatal heart rhythms and saving more lives from cardiac arrest.
- What could go wrong
- This is a small observational study, so results may not apply broadly. The procedure carries risks like bleeding or nerve damage, and it is unclear if it will improve survival compared to standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
62 people
The number who actually took part.
- Started
-
Jun 2019
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All patients with an OHCA occurred in the Province of Pavia in which the first rhythm was a shockable one and with at least three episode of VT/VF during the out-of-hospital resuscitation.
- Ages
-
18 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All patients with an OHCA, occurred in the Province of Pavia, in which the first rhythm was a shockable one and in which the cause of the cardiac arrest is medical (following Utstein-style 2014). * Patients who received L-PSGB after at least 4 unsuccessful shocks during ACLS algorithm; Exclusion Criteria: * Patients in which the cause of the cardiac arrest is non-medical following Utstein-style 2014 (trauma, overdose, drowning, electrocution, asphyxia, etc.) * Patients who has an anisocoria at the arrival of medical doctor on the scene. * Patients whose neck is judge unsuitable for PSGB by the operator (i.e. presence of big scar, thyroid goiter, etc.)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Medical etiology are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione IRCCS Policlinico San Matteo
Pavia, Pavia, 27100, Italy
-
Fondazione IRCCS Policlinico San Matteo
Pavia, PV, 27100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could better phone training save more cardiac arrest victims?
- Can tracking body heat during cardiac arrest improve survival?
- Can emergency response predict heart restart? a new study investigates
- Can big data unlock the secrets of cardiac arrest survival?
- Double shocks: could two defibrillators save more cardiac arrest patients?
- AI measures muscle to predict cardiac arrest recovery